nach oben

Journal of Diabetes & Metabolic Disorders

Erschienen in:

11.05.2019 | Research Article

Plantar pressure distribution in diverse stages of diabetic neuropathy

verfasst von: Homa Abri, Maryam Aalaa, Mahnaz Sanjari, Mohammad Reza Amini, Mohammad Reza Mohajeri-Tehrani, Bagher Larijani

Erschienen in: Journal of Diabetes & Metabolic Disorders | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

Diabetic Foot Ulceration in patients with diabetes could be associated with high plantar pressure caused by diabetes neuropathy. Therefore, it seems that one of the ways of identifying high-risk legs in diabetic patients with neuropathy would be characterization of elevated plantar pressure distributions.

Objective

Comparing the plantar pressure distribution in diabetic patients who suffered neuropathy with those without neuropathy.

Methods and materials

Plantar pressure distribution was recorded in the following categories: 38 diabetic patients without neuropathy, 30, 40 and 34 patients with mild neuropathy, moderate and severe neuropathy respectively.

Results

Patients suffered from severe neuropathy suggested higher maximum peak plantar pressure at midfoot, heel, and medial forefoot. The peak pressure of midfoot was significantly different in the following categories as well: patient without neuropathy (32.3 ± 17.9 kPa), mild neuropathic (24.0 ± 17.9 kPa), moderate neuropathic (21.5 ± 12.6 kPa), and severe neuropathic (22.9 ± 10.7 kPa) groups (p = 0.02).

Conclusion

The progression of diabetic neuropathy would have been increased followed by the peak plantar pressure.

Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047–53.CrossRefPubMed

Cavanagh PR, Simoneau GG, Ulbrecht JS. Ulceration, unsteadiness, and uncertainty: the biomechanical consequences of diabetes mellitus. J Biomech. 1993;26:23–40.CrossRefPubMed

Martin CL, Albers J, Herman WH, Cleary P, Waberski B, Greene DA, et al. Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion. Diabetes Care. 2006;29(2):340–4.CrossRefPubMedPubMedCentral

Control D, Group CTR. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977–86.CrossRef

Pirart J. Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973. Diabetes Care. 1978;1(3):168–88.CrossRef

Said G. Diabetic neuropathy—a review. Nat Clin Pract Neurol. 2007;3(6):331–40.CrossRefPubMed

Bus SA, Maas M, de Lange A, Michels RP, Levi M. Elevated plantar pressures in neuropathic diabetic patients with claw/hammer toe deformity. J Biomech. 2005;38(9):1918–25.CrossRefPubMed

Payne C, Turner D, Miller K. Determinants of plantar pressures in the diabetic foot. J Diabetes Complicat. 2002;16(4):277–83.CrossRefPubMed

Fernando DJ, Masson EA, Veves A, Boulton AJ. Relationship of limited joint mobility to abnormal foot pressures and diabetic foot ulceration. Diabetes Care. 1991;14(1):8–11.CrossRefPubMed

10.

Cavanagh PR, Ulbrecht JS. Biomechanics of the diabetic foot: a quantitative approach to the assessment of neuropathy, deformity and plantar pressure. In: Disorders of the foot and ankle: medical and surgical management, vol. 2; 1991. p. 1864–907.

11.

Kwon O-Y, Minor SD, Maluf KS, Mueller MJ. Comparison of muscle activity during walking in subjects with and without diabetic neuropathy. Gait Posture. 2003;18(1):105–13.CrossRefPubMed

12.

Mueller MJ, Minor SD, Sahrmann SA, Schaaf JA, Strube MJ. Differences in the gait characteristics of patients with diabetes and peripheral neuropathy compared with age-matched controls. Phys Ther. 1994;74(4):299–308.CrossRefPubMed

13.

Maluf K, Mueller M, Strube M, Engsberg J, Johnson J. Tendon Achilles lengthening for the treatment of neuropathic ulcers causes a temporary reduction in forefoot pressure associated with changes in plantar flexor power rather than ankle motion during gait. J Biomech. 2004;37(6):897–906.CrossRefPubMed

14.

Shaw JE, Van Schie C, Carrington AL, Abbott CA, Boulton A. An analysis of dynamic forces transmitted through the foot in diabetic neuropathy. Diabetes Care. 1998;21(11):1955–9.CrossRefPubMed

15.

Sacco I, Amadio A. Influence of the diabetic neuropathy on the behavior of electromyographic and sensorial responses in treadmill gait. Clin Biomech. 2003;18(5):426–34.CrossRef

16.

Stess RM, Jensen SR, Mirmiran R. The role of dynamic plantar pressures in diabetic foot ulcers. Diabetes Care. 1997;20(5):855–8.CrossRefPubMed

17.

Frykberg RG, Lavery LA, Pham H, Harvey C, Harkless L, Veves A. Role of neuropathy and high foot pressures in diabetic foot ulceration. Diabetes Care. 1998;21(10):1714–9.CrossRefPubMed

18.

Bacarin TA, Sacco IC, Hennig EM. Plantar pressure distribution patterns during gait in diabetic neuropathy patients with a history of foot ulcers. Clinics. 2009;64(2):113–20.CrossRefPubMedPubMedCentral

19.

Stokes I, Faris I, Hutton W. The neuropathic ulcer and loads on the foot in diabetic patients. Acta Orthopaedica Scandinavica. 2009.

20.

Caselli A, Pham H, Giurini JM, Armstrong DG, Veves A. The forefoot-to-rearfoot plantar pressure ratio is increased in severe diabetic neuropathy and can predict foot ulceration. Diabetes Care. 2002;25(6):1066–71.CrossRefPubMed

21.

Pham H, Armstrong DG, Harvey C, Harkless LB, Giurini JM, Veves A. Screening techniques to identify people at high risk for diabetic foot ulceration: a prospective multicenter trial. Diabetes Care. 2000;23(5):606–11.CrossRefPubMed

22.

Veves A, Murray H, Young M, Boulton A. The risk of foot ulceration in diabetic patients with high foot pressure: a prospective study. Diabetologia. 1992;35(7):660–3.CrossRefPubMed

23.

Rich J, Veves A. Forefoot and rearfoot plantar pressures in diabetic patients: correlation to foot ulceration. WOUNDS-A COMPENDIUM OF CLINICAL RESEARCH AND PRACTICE. 2000;12(4):82–7.

24.

Reiber GE, Smith DG, Wallace C, Sullivan K, Hayes S, Vath C, et al. Effect of therapeutic footwear on foot reulceration in patients with diabetes: a randomized controlled trial. JAMA. 2002;287(19):2552–8.CrossRefPubMed

25.

Lavery LA, Vela SA, Fleischli JG, Armstrong DG, Lavery DC. Reducing plantar pressure in the neuropathic foot: a comparison of footwear. Diabetes Care. 1997;20(11):1706–10.CrossRefPubMed

26.

Sarnow MR, Veves A, Giurini JM, Rosenblum BI, Chrzan JS, Habershaw GM. In-shoe foot pressure measurements in diabetic patients with at-risk feet and in healthy subjects. Diabetes Care. 1994;17(9):1002–6.CrossRefPubMed

27.

Abouaesha F, van Schie CH, Griffths GD, Young RJ, Boulton AJ. Plantar tissue thickness is related to peak plantar pressure in the high-risk diabetic foot. Diabetes Care. 2001;24(7):1270–4.CrossRefPubMed

28.

Schoenhaus H, Wernick E, Cohen R. Biomechanics of the diabetic foot. The high risk foot in diabetes mellitus. 1991;125.

29.

Young M, Cavanagh P, Thomas G, Johnson M, Murray H, Boulton A. The effect of callus removal on dynamic plantar foot pressures in diabetic patients. Diabet Med. 1992;9(1):55–7.CrossRefPubMed

30.

Mueller MJ. Application of plantar pressure assessment in footwear and insert design. J Orthop Sports Phys Ther. 1999;29(12):747–55.CrossRefPubMed

31.

Cavanagh PR, Owings TM. Nonsurgical strategies for healing and preventing recurrence of diabetic foot ulcers. Foot Ankle Clin. 2006;11(4):735–43.CrossRefPubMed

32.

Cavanagh PR, Bus SA. Off-loading the diabetic foot for ulcer prevention and healing. J Am Podiatr Med Assoc. 2010;100(5):360–8.CrossRefPubMed

33.

Yavuz M, Erdemir A, Botek G, Hirschman GB, Bardsley L, Davis BL. Peak plantar pressure and shear locations relevance to diabetic patients. Diabetes Care. 2007;30(10):2643–5.CrossRefPubMed

34.

Giacomozzi C, Caselli A, Macellari V, Giurato L, Lardieri L, Uccioli L. Walking strategy in diabetic patients with peripheral neuropathy. Diabetes Care. 2002;25(8):1451–7.CrossRefPubMed

35.

Sinacore DR, Bohnert KL, Hastings MK, Johnson JE. Mid foot kinetics characterize structural polymorphism in diabetic foot disease. Clin Biomech. 2008;23(5):653–61.CrossRef

36.

Sacco I, Amadio A. A study of biomechanical parameters in gait analysis and sensitive cronaxie of diabetic neuropathic patients. Clin Biomech. 2000;15(3):196–202.CrossRef

37.

Fang F, Wang Y, Gu M, Chen H, Wang D, Xiao K, et al. Pedobarography-a novel screening tool for diabetic peripheral neuropathy. Eur Rev Med Pharmacol Sci. 2013;17(23):3206–12.PubMed

38.

Syed N, Maiya A, Hanifa N, Goud S. Plantar pressures in diabetes with no known neuropathy. Journal of diabetes. 2013;5(3):302–8.CrossRefPubMed

39.

Adler A. Risk factors for diabetic neuropathy and foot ulceration. Current diabetes reports. 2001;1(3):202–7.CrossRefPubMed

40.

Taylor AJ, Menz HB, Keenan A-M. Effects of experimentally induced plantar insensitivity on forces and pressures under the foot during normal walking. Gait Posture. 2004;20(3):232–7.CrossRefPubMed

41.

Shen J, Liu F, Zeng H, Wang J, Zhao J-G, Zhao J, et al. Vibrating perception threshold and body mass index are associated with abnormal foot plantar pressure in type 2 diabetes outpatients. Diabetes Technol Ther. 2012;14(11):1053–9.CrossRefPubMedPubMedCentral

42.

Salsich GB, Mueller MJ, Sahrmann SA. Passive ankle stiffness in subjects with diabetes and peripheral neuropathy versus an age-matched comparison group. Phys Ther. 2000;80(4):352–62.CrossRefPubMed

43.

Gefen A. Plantar soft tissue loading under the medial metatarsals in the standing diabetic foot. Med Eng Phys. 2003;25(6):491–9.CrossRefPubMed

44.

Turner D, Helliwell PS, Burton AK, Woodburn J. The relationship between passive range of motion and range of motion during gait and plantar pressure measurements. Diabet Med. 2007;24(11):1240–6.CrossRefPubMed

45.

Waaijman R, Bus S. The interdependency of peak pressure and pressure–time integral in pressure studies on diabetic footwear: no need to report both parameters. Gait Posture. 2012;35(1):1–5.CrossRefPubMed

Titel: Plantar pressure distribution in diverse stages of diabetic neuropathy
verfasst von: Homa Abri
Maryam Aalaa
Mahnaz Sanjari
Mohammad Reza Amini
Mohammad Reza Mohajeri-Tehrani
Bagher Larijani
Publikationsdatum: 11.05.2019
Verlag: Springer International Publishing
Erschienen in: Journal of Diabetes & Metabolic Disorders / Ausgabe 1/2019
Elektronische ISSN: 2251-6581
DOI: https://doi.org/10.1007/s40200-019-00387-1

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

23.04.2024 | Ablationstherapie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Plantar pressure distribution in diverse stages of diabetic neuropathy

Abstract

Background

Objective

Methods and materials

Results

Conclusion

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

Europäische Ernährungsgewohnheiten: Das sind die häufigsten Fehler

Hinter dieser Appendizitis steckte ein Erreger

Demenzkranke durch Antipsychotika vielfach gefährdet

Update Innere Medizin

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Background

Objective

Methods and materials

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2019

Prospective of managing impaired brain insulin signalling in late onset Alzheimers disease with excisting diabetic drugs

The use of conversation maps in the metabolic control of diabetes in Brazilians: a randomized clinical trial

Rice bran oil ameliorates hepatic insulin resistance by improving insulin signaling in fructose fed-rats

Effect of diabetes on BMD and TBS values as determinants of bone health in the elderly: Bushehr Elderly Health program

Healthcare resource utilization and cost of care for Gaucher patients in Iran

Novel ambulatory glucose-sensing technology improves hypoglycemia detection and patient monitoring adherence in children and adolescents with type 1 diabetes

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

Europäische Ernährungsgewohnheiten: Das sind die häufigsten Fehler

Hinter dieser Appendizitis steckte ein Erreger

Demenzkranke durch Antipsychotika vielfach gefährdet

Update Innere Medizin